We are live on
!
Find out more
ACA
Apis Capital Advisors Portfolio holdings
AUM
$648M
1-Year Est. Return
302.67%
This Fund
S&P 500
This Quarter
Est. Return
+5.05%
1 Year Est. Return
+302.67%
3 Year Est. Return
+1,035.2%
5 Year Est. Return
+2,376.05%
10 Year Est. Return
–
AUM
$63.8M
AUM Growth
-$3.01M
(-4.5%)
Cap. Flow
-$2.12M
Cap. Flow
% of AUM
-3.33%
Top 10 Holdings %
Top 10 Hldgs %
76.23%
Holding
39
New
8
Increased
12
Reduced
6
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tandem Diabetes Care
TNDM
|
+$3.19M |
| 2 |
Zebra Technologies
ZBRA
|
+$2.42M |
| 3 |
WIFI
Boingo Wireless, Inc.
WIFI
|
+$1.41M |
| 4 |
Vicor
VICR
|
+$1.23M |
| 5 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
+$1.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMRN
Amarin Corp
AMRN
|
+$6.5M |
| 2 |
Golar LNG
GLNG
|
+$1.76M |
| 3 |
Match Group
MTCH
|
+$1.55M |
| 4 |
Verisk Analytics
VRSK
|
+$1.32M |
| 5 |
Sarepta Therapeutics
SRPT
|
+$1.29M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.23% |
| 2 | Healthcare | 28.08% |
| 3 | Consumer Discretionary | 12.22% |
| 4 | Energy | 11.39% |
| 5 | Communication Services | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Establishment Labs
ESTA
$2.72B
| $473K | 0.74% |
25,000
+3,000
| +14% | +$64.5K |
|
|
OPNT
27
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
| $256K | 0.4% |
+17,000
| New | +$237K |
|
28
Forte Biosciences
FBRX
$1.57B
| – | – |
-53
| Closed | -$134K |
|
|
29
Golar LNG
GLNG
$5B
| – | – |
-95,000
| Closed | -$1.76M |
|
30
LiqTech
LIQT
$23M
| – | – |
-6,250
| Closed | -$496K |
|
31
Marker Therapeutics
MRKR
$18.8M
| – | – |
-9,000
| Closed | -$713K |
|
|
32
Match Group
MTCH
$9.19B
| – | – |
-23,000
| Closed | -$1.55M |
|
33
Silicon Motion
SIMO
$8.6B
| – | – |
-28,500
| Closed | -$1.26M |
|
|
34
Sarepta Therapeutics
SRPT
$1.57B
| – | – |
-8,500
| Closed | -$1.29M |
|
|
35
Verisk Analytics
VRSK
$25.4B
| – | – |
-9,000
| Closed | -$1.32M |
|
|
OSG
36
DELISTED
Overseas Shipholding Group Inc.
OSG
| – | – |
-11,000
| Closed | -$21K |
|
|
AERI
37
DELISTED
Aerie Pharmaceuticals
AERI
| – | – |
-20,000
| Closed | -$591K |
|
|
DSPG
38
DELISTED
DSP Group Inc
DSPG
| – | – |
-49,980
| Closed | -$718K |
|
|
I
39
DELISTED
INTELSAT S. A.
I
| – | – |
-48,000
| Closed | -$934K |
|
Similar funds
TWP
CAAM
GAMA
RK
PCM
ITC
CCA
SCM
Apis Capital Advisors's Q3 2019 Portfolio in Review
As of Q3 2019, Apis Capital Advisors held 39 positions worth $63.8M, down 4.5% from $66.8M the previous quarter. Its ten largest holdings account for 76% of the portfolio.
Apis Capital Advisors withdrew a net $2.12M in Q3 2019, closing 12 positions and reducing 6 holdings. Its most notable exit was Golar LNG, an estimated $1.76M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Apis Capital Advisors opened a new position in Tandem Diabetes Care worth $2.95M.
- Apis Capital Advisors's largest Q3 2019 buy was Tandem Diabetes Care: 50,000 shares worth $2.95M.
- Apis Capital Advisors added most to Vicor in Q3 2019, an estimated $1.23M increase.
- Apis Capital Advisors's biggest Q3 2019 reduction was Amarin Corp, cutting an estimated $6.5M.
- Apis Capital Advisors fully exited Golar LNG in Q3 2019, selling an estimated $1.76M.
- Apis Capital Advisors's ten largest holdings make up 76% of its $63.8M portfolio in Q3 2019.
- Apis Capital Advisors opened 8 new positions and closed 12 in Q3 2019.
- Apis Capital Advisors's portfolio value fell 4.5% quarter-over-quarter to $63.8M.
Based on Apis Capital Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.